Amolyt Pharma développe des traitements potentiels dans les maladies endocriniennes rares, notamment contre l'hypoparathyroïdie.
BUSINESSES
Amolyt Pharma
PITCH
RECENT INVESTMENT(S)
06.19
Série A
34.0 M€
01.23
Série C
130.0 M€
Submit information
Want to send us some news? An opinion or an idea? Anonymously or not, we'd love to hear from you
Submit information
Want to send us some news? An opinion or an idea? Anonymously or not, we'd love to hear from you
